EHealth Research Development vs Other Operating Expenses Analysis
EHTH Stock | USD 5.36 0.15 2.88% |
EHealth financial indicator trend analysis is much more than just examining eHealth latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether eHealth is a good investment. Please check the relationship between EHealth Research Development and its Other Operating Expenses accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.
Research Development vs Other Operating Expenses
Research Development vs Other Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of eHealth Research Development account and Other Operating Expenses. At this time, the significance of the direction appears to have very strong relationship.
The correlation between EHealth's Research Development and Other Operating Expenses is 0.89. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of eHealth, assuming nothing else is changed. The correlation between historical values of EHealth's Research Development and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of eHealth are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Research Development i.e., EHealth's Research Development and Other Operating Expenses go up and down completely randomly.
Correlation Coefficient | 0.89 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Research Development
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of eHealth. It is also known as EHealth overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most indicators from EHealth's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into eHealth current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.As of now, EHealth's Tax Provision is decreasing as compared to previous years. The EHealth's current Sales General And Administrative To Revenue is estimated to increase to 0.35, while Selling General Administrative is projected to decrease to under 46.8 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 536.2M | 403.7M | 431.2M | 218.0M | Total Revenue | 538.2M | 405.4M | 452.9M | 475.5M |
EHealth fundamental ratios Correlations
Click cells to compare fundamentals
EHealth Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EHealth fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 741.6M | 1.0B | 1.1B | 1.1B | 1.3B | 1.4B | |
Total Stockholder Equity | 527.2M | 837.6M | 982.1M | 914.2M | 904.1M | 949.3M | |
Retained Earnings | 271.9M | 316.2M | 193.2M | 73.8M | 7.3M | 6.9M | |
Other Assets | 421.3M | 603.1M | 690.3M | 648.2M | 202.9M | 147.4M | |
Common Stock Shares Outstanding | 24.5M | 27.0M | 26.8M | 27.4M | 28.0M | 21.4M | |
Liabilities And Stockholders Equity | 741.6M | 1.0B | 1.1B | 1.1B | 1.3B | 1.4B | |
Other Stockholder Equity | 255.2M | 521.0M | 555.9M | 577.2M | 598.8M | 628.7M | |
Total Liab | 214.5M | 202.5M | 167.2M | 198.4M | 412.1M | 432.8M | |
Other Current Liab | 81.1M | 42.0M | 3.3M | 15.0M | 64.4M | 67.6M | |
Total Current Liabilities | 113.0M | 84.4M | 75.5M | 60.6M | 78.5M | 40.2M | |
Other Liab | 67.2M | 76.7M | 55.9M | 37.5M | 43.1M | 22.7M | |
Property Plant And Equipment Net | 47.1M | 57.2M | 49.5M | 32.0M | 27.6M | 16.2M | |
Current Deferred Revenue | 2.6M | 308K | 52.8M | 32.4M | (127K) | (120.7K) | |
Net Debt | 15.6M | 2.8M | (40.6M) | (37.6M) | (12.6M) | (13.2M) | |
Accounts Payable | 24.6M | 36.9M | 13.8M | 6.7M | 7.2M | 7.6M | |
Cash | 23.5M | 43.8M | 81.9M | 144.4M | 115.7M | 85.4M | |
Non Current Assets Total | 533.5M | 709.0M | 741.7M | 711.5M | 731.0M | 767.5M | |
Non Currrent Assets Other | 21.4M | 603.1M | 690.3M | 612.6M | (134.4M) | (127.7M) | |
Cash And Short Term Investments | 23.5M | 93.4M | 123.2M | 144.4M | 121.7M | 97.3M | |
Net Receivables | 176.9M | 221.0M | 260.6M | 245.4M | 922.2M | 968.3M | |
Common Stock Total Equity | 35K | 38K | 39K | 40K | 46K | 29.8K | |
Non Current Liabilities Total | 101.5M | 118.1M | 91.7M | 137.8M | 130.7M | 137.3M | |
Other Current Assets | 2.4M | 595K | 922K | 11.3M | (1.0B) | (991.6M) | |
Property Plant And Equipment Gross | 47.1M | 57.2M | 49.5M | 32.0M | 38.8M | 40.7M | |
Total Current Assets | 208.1M | 331.0M | 407.6M | 401.1M | 382.4M | 401.5M | |
Accumulated Other Comprehensive Income | 116K | 350K | 390K | (73K) | (82K) | (77.9K) | |
Short Term Debt | 4.8M | 5.2M | 5.5M | 6.5M | 7.1M | 9.8M | |
Intangible Assets | 10.1M | 8.6M | 1.9M | 31.3M | 23.6M | 24.8M | |
Common Stock | 35K | 38K | 39K | 40K | 41K | 30.5K | |
Property Plant Equipment | 10.5M | 14.6M | 49.5M | 5.5M | 6.3M | 9.4M | |
Short Long Term Debt Total | 39.1M | 46.6M | 41.4M | 106.8M | 103.2M | 53.8M | |
Inventory | 5.5M | 16.1M | 22.9M | 1.0 | 0.9 | 0.86 | |
Net Tangible Assets | 511.2M | 830.1M | 747.6M | 914.2M | 1.1B | 1.1B | |
Retained Earnings Total Equity | 271.9M | 316.2M | 193.2M | 73.8M | 84.9M | 101.3M | |
Capital Surpluse | 455.2M | 721.0M | 755.9M | 777.2M | 893.8M | 472.6M | |
Deferred Long Term Liab | 64.1M | 72.3M | 50.8M | 32.4M | 37.2M | 26.0M |
Currently Active Assets on Macroaxis
When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for EHealth Stock analysis
When running EHealth's price analysis, check to measure EHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EHealth is operating at the current time. Most of EHealth's value examination focuses on studying past and present price action to predict the probability of EHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EHealth's price. Additionally, you may evaluate how the addition of EHealth to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Stocks Directory Find actively traded stocks across global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is EHealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.108 | Earnings Share (2.39) | Revenue Per Share 16.664 | Quarterly Revenue Growth 0.261 | Return On Assets (0.01) |
The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.